SE0001865D0 - Management of septic shock - Google Patents

Management of septic shock

Info

Publication number
SE0001865D0
SE0001865D0 SE0001865A SE0001865A SE0001865D0 SE 0001865 D0 SE0001865 D0 SE 0001865D0 SE 0001865 A SE0001865 A SE 0001865A SE 0001865 A SE0001865 A SE 0001865A SE 0001865 D0 SE0001865 D0 SE 0001865D0
Authority
SE
Sweden
Prior art keywords
septic shock
pharmaceutical composition
management
sterile pharmaceutical
medicament
Prior art date
Application number
SE0001865A
Other languages
English (en)
Inventor
Arne Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0001865A priority Critical patent/SE0001865D0/sv
Publication of SE0001865D0 publication Critical patent/SE0001865D0/sv
Priority to US09/849,591 priority patent/US20020037933A1/en
Priority to AU2001254990A priority patent/AU2001254990A1/en
Priority to CN01809726A priority patent/CN1430509A/zh
Priority to CA002407540A priority patent/CA2407540A1/en
Priority to IL15247101A priority patent/IL152471A0/xx
Priority to BR0110982-0A priority patent/BR0110982A/pt
Priority to KR1020027015536A priority patent/KR20020097482A/ko
Priority to JP2001583757A priority patent/JP2003533476A/ja
Priority to MXPA02011240A priority patent/MXPA02011240A/es
Priority to PCT/GB2001/002117 priority patent/WO2001087289A2/en
Priority to EP01928126A priority patent/EP1296664A2/en
Priority to ZA200208893A priority patent/ZA200208893B/en
Priority to NO20025530A priority patent/NO20025530L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
SE0001865A 2000-05-19 2000-05-19 Management of septic shock SE0001865D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock
US09/849,591 US20020037933A1 (en) 2000-05-19 2001-05-07 Management of septic shock
EP01928126A EP1296664A2 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
BR0110982-0A BR0110982A (pt) 2000-05-19 2001-05-15 Composição farmacêutica estéril para administração parenteral, uso do composto 2,6-diisopropil-fenol (propofol), uso de uma composição farmacêutica estéril para administração parenteral, método de manejo do choque séptico, e, método de contraposição à deterioração induzida por endotoxina da tensão de oxigênio arterial
CN01809726A CN1430509A (zh) 2000-05-19 2001-05-15 控制败血症性休克
CA002407540A CA2407540A1 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
IL15247101A IL152471A0 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
AU2001254990A AU2001254990A1 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
KR1020027015536A KR20020097482A (ko) 2000-05-19 2001-05-15 패혈증 치료용 프로포폴
JP2001583757A JP2003533476A (ja) 2000-05-19 2001-05-15 敗血症ショックの治療
MXPA02011240A MXPA02011240A (es) 2000-05-19 2001-05-15 Manejo de choque septico.
PCT/GB2001/002117 WO2001087289A2 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
ZA200208893A ZA200208893B (en) 2000-05-19 2002-11-01 Propofol for treatment of sepsis.
NO20025530A NO20025530L (no) 2000-05-19 2002-11-18 Håndtering av septisk sjokk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock

Publications (1)

Publication Number Publication Date
SE0001865D0 true SE0001865D0 (sv) 2000-05-19

Family

ID=20279747

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock

Country Status (14)

Country Link
US (1) US20020037933A1 (sv)
EP (1) EP1296664A2 (sv)
JP (1) JP2003533476A (sv)
KR (1) KR20020097482A (sv)
CN (1) CN1430509A (sv)
AU (1) AU2001254990A1 (sv)
BR (1) BR0110982A (sv)
CA (1) CA2407540A1 (sv)
IL (1) IL152471A0 (sv)
MX (1) MXPA02011240A (sv)
NO (1) NO20025530L (sv)
SE (1) SE0001865D0 (sv)
WO (1) WO2001087289A2 (sv)
ZA (1) ZA200208893B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000010531A1 (en) * 1998-08-19 2000-03-02 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
RU2297216C2 (ru) * 2002-04-08 2007-04-20 Эм-Джи-Ай Джи-Пи,Инк. Фармацевтические композиции, содержащие растворимые в воде пролекарства пропофола, и способы их применения
WO2003105817A1 (en) * 2002-05-02 2003-12-24 Fdl, Inc. Novel parenteral composition comprising propofol
BRPI0614084A2 (pt) * 2005-08-05 2011-03-09 Bharat Serums & Vaccines Ltd composição estável de emulsão de óleo-em-água de propofol, administrável por via intranovesa; e processo de preparação de uma composição
US7727730B2 (en) * 2005-12-09 2010-06-01 Corgenix Medical Corporation Methods and kits for detection of thromboxane A2 metabolites
EP2516369B1 (en) * 2010-06-23 2015-07-22 Harman Finochem Limited Process for preparing extra pure 2, 6-diisopropyl phenol
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
CN109470762B (zh) * 2017-09-07 2020-12-29 中国科学院大连化学物理研究所 一种准确识别丙泊酚注射液是否过期的方法
CA3119792A1 (en) * 2018-11-15 2020-05-22 Ferring B.V. Compounds, compositions and methods for treating sepsis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
WO2001087289A2 (en) 2001-11-22
NO20025530L (no) 2003-01-14
WO2001087289A3 (en) 2002-05-16
ZA200208893B (en) 2004-02-19
KR20020097482A (ko) 2002-12-31
JP2003533476A (ja) 2003-11-11
MXPA02011240A (es) 2003-03-10
NO20025530D0 (no) 2002-11-18
EP1296664A2 (en) 2003-04-02
CA2407540A1 (en) 2001-11-22
AU2001254990A1 (en) 2001-11-26
BR0110982A (pt) 2003-04-08
CN1430509A (zh) 2003-07-16
US20020037933A1 (en) 2002-03-28
IL152471A0 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
BR9913221A (pt) Composições catalisadoras sustentadas altamente ativas
CY1106970T1 (el) Συνθεση προποφολης (propofol) περιεχουσα θειωδες αλας
BR0317822A (pt) Composição fluoroquìmica
PA8486001A1 (es) Composiciones de celecoxib
UY26092A1 (es) Uso de inhibidores de cyp2d6 en terapias de combinacion
SE0301886D0 (sv) New use V
ID28263A (id) DIPEPTIDA OKSAMIL TERMODIFIKASI C-TERMINAL SEBAGAI PENGHAMBAT PADA KELUARGA ICE-ced-3 DARI PROTEASE SISTEINA
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
CO5700796A2 (es) Composiciones que contienen piperacilina y tazobactam utiles para inyecciones
SE0301882D0 (sv) New use I
ECSP034600A (es) Compuestos de lactama
MXPA05001061A (es) Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol.
SE0001865D0 (sv) Management of septic shock
ECSP066548A (es) 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica
KR960700217A (ko) 액체 페놀성 산화방지제
FR2818906B1 (fr) Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine
ATE468381T1 (de) Neuer kraftstoff mit hoher oktanzahl und geringem aromatengehalt
BR0000544A (pt) Poliolefinas de metaloceno estabilizadas
AR043253A1 (es) 4-[(2,4-dicloro-5-metoxifenil)amino] -6- alcoxi-3-quinolina carbonitrilos para el tratamiento de lesiones isquemicas
WO2008059130A9 (fr) Thionucléosides et applications pharmaceutiques
EA199901012A1 (ru) Фармацевтические композиции на основе тизоксанида и нитазоксанида
UY27394A1 (es) Pedidos con actividad anti- angiogéna.
RS4904A (en) Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions
SE0301885D0 (sv) New use IV